Home > Insider Trading > Filing (0001209191-10-025175)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1389072	Heartware International Inc.	HTWR	Surgical & Medical Instruments & Apparatus (3841)	980498958

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1419219	James Schuermann	C/O Heartware International, Inc. 205 Newbury Street, Suite 101 Framingham MA 01701	Vp, Sales & Marketing	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-05-03	6,428	$24.24	8,843	No	4	M	Direct
Common Stock	Disposition	2010-05-03	8,843	$55.69	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2010-05-03	6,428	$0.00	6,428	$24.24

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2010-02-22	2017-11-16	No	4	M	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Restricted Stock Unit	$0.00		2019-09-16	30,000	30,000	Direct
Common Stock	Restricted Stock Unit	$0.00	2011-02-22	2018-08-13	1,785	1,785	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2019-09-16	30,000	30,000	Direct
2018-08-13	1,785	1,785	Direct

Footnotes

The purchase price of US$24.24 has been converted from AU$26.25 at the spot rate on the date of the transaction.
These shares were sold pursuant to a pre-arranged trading plan adopted by the reporting person on March 17, 2010 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $53.12 to $57.69. The reporting person has provided the issuer and will provide any security holder of the issuer or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range.
The exercise price of US$24.24 has been converted from AU$26.25 at the spot rate on the date of the transaction.
Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
The restricted stock units become exercisable in three equal installments on September 16, 2010, September 16, 2011 and September 16, 2012, respectively.